Zhejiang Jolly Pharmaceutical Co Ltd (300181) — Financial Flexibility Index
Zhejiang Jolly Pharmaceutical Co Ltd (300181) has a Financial Flexibility Index of 0.03x as of September 2025. Free cash flow of CN¥39.97 Million (operating CF CN¥-23.58 Million minus capex CN¥63.55 Million) represents 0% of total liabilities (CN¥1.46 Billion). Check Zhejiang Jolly Pharmaceutical Co Ltd (300181) strategic investment index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zhejiang Jolly Pharmaceutical Co Ltd Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for Zhejiang Jolly Pharmaceutical Co Ltd across 19 annual periods. See Zhejiang Jolly Pharmaceutical Co Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Zhejiang Jolly Pharmaceutical Co Ltd (2007–2025)
Year-by-year free cash flow to debt coverage for Zhejiang Jolly Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 300181 company net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.48x | CN¥698.95 Million | CN¥411.80 Million | CN¥1.47 Billion | ▼ -0.5% |
| 2024 | 0.48x | CN¥559.94 Million | CN¥297.05 Million | CN¥1.17 Billion | ▼ -3.0% |
| 2023 | 0.49x | CN¥420.18 Million | CN¥288.46 Million | CN¥853.09 Million | ▼ -12.8% |
| 2022 | 0.56x | CN¥496.63 Million | CN¥318.59 Million | CN¥879.19 Million | ▲ +8.1% |
| 2021 | 0.52x | CN¥399.75 Million | CN¥251.80 Million | CN¥765.31 Million | ▲ +16.0% |
| 2020 | 0.45x | CN¥338.04 Million | CN¥279.69 Million | CN¥750.43 Million | ▲ +70.9% |
| 2019 | 0.26x | CN¥169.40 Million | CN¥128.94 Million | CN¥642.86 Million | ▼ -17.6% |
| 2018 | 0.32x | CN¥232.21 Million | CN¥78.28 Million | CN¥726.50 Million | ▲ +61.7% |
| 2017 | 0.20x | CN¥130.90 Million | CN¥6.51 Million | CN¥662.06 Million | ▼ -44.5% |
| 2016 | 0.36x | CN¥201.55 Million | CN¥58.30 Million | CN¥566.00 Million | ▲ +19.9% |
| 2015 | 0.30x | CN¥123.21 Million | CN¥97.13 Million | CN¥414.94 Million | ▲ +73.6% |
| 2014 | 0.17x | CN¥52.99 Million | CN¥13.70 Million | CN¥309.75 Million | ▼ -45.6% |
| 2013 | 0.31x | CN¥53.23 Million | CN¥29.50 Million | CN¥169.38 Million | ▼ -26.4% |
| 2012 | 0.43x | CN¥67.55 Million | CN¥30.51 Million | CN¥158.27 Million | ▼ -8.9% |
| 2011 | 0.47x | CN¥74.98 Million | CN¥13.65 Million | CN¥159.99 Million | ▼ -35.9% |
| 2010 | 0.73x | CN¥103.46 Million | CN¥64.78 Million | CN¥141.47 Million | ▲ +52.1% |
| 2009 | 0.48x | CN¥63.49 Million | CN¥43.89 Million | CN¥132.07 Million | ▲ +44.0% |
| 2008 | 0.33x | CN¥43.66 Million | CN¥31.16 Million | CN¥130.76 Million | ▲ +41.7% |
| 2007 | 0.24x | CN¥25.17 Million | CN¥16.05 Million | CN¥106.79 Million | — |